An energetic ACC patient community is inspiring a global ACC research community! Two recent scientific conferences demonstrated how ACC researchers are understanding the disease better and, therefore, are developing better treatments.

On December 1, 2018, in Shanghai, China, ACC patients and clinicians gathered for a major ACC event. In the morning, more than 50 ACC patients attended a   large-scale clinic in which they consulted with experts from the Shanghai Ninth People's Hospital affiliated with the Shanghai Jiao Tong University School of Medicine. Later, in the afternoon, 50 physicians and researchers met to hear scientific presentations and discussions, including a video lecture by ACCRF Executive Director Jeff Kaufman. More than 1,700 viewers watched the live webcast. The remarkable day was organized by Drs. Chenping Zhang and Guopei Zhu, both of whom were instrumental in orchestrating the recent promising clinical trial of the novel drug Apatinib.

On March 15 and 16, 2019, in Boston, MA, USA, scientists gathered for the "Advances in ACC Translational Research" conference. Hosted by Drs. Derrick Lin, Lori Wirth and Sara Pai of the Massachusetts Eye & Ear Infirmary and Massachusetts General Hospital, the event brought together more than 70 attendees from Australia, China, the United Kingdom and the United States to hear presentations on the newest preclinical models, genomic studies, treatment concepts and clinical trials. ACCRF co-sponsored the event. The program for the conference is available here.